SCHEDULE 13G

Statement of Beneficial Ownership

Apimeds Pharmaceuticals US, Inc. Filed 2026-02-11 Acc 0001493152-26-006136

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-17 425 Prospectus/Communication re Business Combination
2026-02-17 8-K/A Acquisition or sale completed
2026-02-11 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)